Abstract
摘要
相似文献
1
Agammaglobulinemia.无丙种球蛋白血症
Pediatrics. 1952 Jun;9(6):722-8.
2
[CHANGES IN THE PROTEIN FRACTIONS OF BLOOD SERUM CAUSED BY RADIATION THERAPY].[放射治疗引起的血清蛋白组分变化]
Med Radiol (Mosk). 1963 Nov;8:24-30.
3
[A new biological disorder: agammaglobulinemia with beta2-macroglobulinemia (a case)].[一种新的生物紊乱：伴有β2-巨球蛋白血症的无丙种球蛋白血症（一例）]
Bull Mem Soc Med Hop Paris. 1960;76:519-23.
4
5
Immunity: properdin, agammaglobulinemia, irradiation and immunologic paralysis.免疫：备解素、丙种球蛋白缺乏血症、辐射与免疫麻痹。
Annu Rev Med. 1956;7:385-414. doi: 10.1146/annurev.me.07.020156.002125.
6
[SERODIAGNOSIS OF IMMUNOLOGICAL DISEASES].[免疫性疾病的血清学诊断]
Orv Hetil. 1963 Aug 25;104:1585-9.
7
[beta-paraproteinosis (atypical macroglobulinemia and hypo-gamma-globulinemia in bronchial carcinoma].[β-副蛋白血症（支气管癌中的非典型巨球蛋白血症和低γ球蛋白血症）]
Z Gesamte Inn Med. 1960 Oct 15;15:977-8.
8
Immunoglobulin levels from the newborn period to adulthood and in immunoglobulin deficiency states.从新生儿期到成年期以及免疫球蛋白缺乏状态下的免疫球蛋白水平。
J Clin Invest. 1962 Nov;41(11):2054-64. doi: 10.1172/JCI104663.
9
[HEREDITARY HYPOPLASIA OF THE THYMUS AND LYMPHOCYTIC APLASIA].[胸腺遗传性发育不全与淋巴细胞发育不全]
Presse Med (1893). 1965 Feb 6;73:339-40.
10
RECURRENT INFECTIONS AND IMMUNE DEFICIENT STATES IN CHILDREN.儿童复发性感染与免疫缺陷状态
Calif Med. 1964 Jul;101(1):9-14.
引用本文的文献
1
The impact of intravenous immunoglobulin therapy on resource utilization associated with viral respiratory tract infections.静脉注射免疫球蛋白疗法对与病毒性呼吸道感染相关的资源利用的影响。
Front Immunol. 2025 Aug 6;16:1513712. doi: 10.3389/fimmu.2025.1513712. eCollection 2025.
2
Evaluating rilzabrutinib in the treatment of immune thrombocytopenia.评估利扎布替尼治疗免疫性血小板减少症的效果。
Immunotherapy. 2025 Aug;17(11):767-782. doi: 10.1080/1750743X.2025.2545170. Epub 2025 Aug 11.
3
Malignancy in neuromuscular patients on chronic IVIG.接受长期静脉注射免疫球蛋白治疗的神经肌肉疾病患者发生恶性肿瘤的情况。
Front Neurol. 2025 Jun 24;16:1571160. doi: 10.3389/fneur.2025.1571160. eCollection 2025.
4
Current and future landscape of Bruton tyrosine kinase inhibitors in allergy.布鲁顿酪氨酸激酶抑制剂在过敏领域的现状与未来前景
J Allergy Clin Immunol. 2025 Jun 16. doi: 10.1016/j.jaci.2025.05.030.
5
Bruton Tyrosine Kinase in Lesions of Multiple Sclerosis and 3 of Its Models.布鲁顿酪氨酸激酶在多发性硬化症及其三种模型病变中的作用
Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200413. doi: 10.1212/NXI.0000000000200413. Epub 2025 May 29.
6
Identifying genetic errors of immunity due to mosaicism.识别由嵌合体引起的免疫基因错误。
J Exp Med. 2025 May 5;222(5). doi: 10.1084/jem.20241045. Epub 2025 Apr 15.
7
Soluble Factors and Mechanisms Regulated by Sialylated IgG Signaling.唾液酸化IgG信号调节的可溶性因子和机制
Immunol Rev. 2025 Mar;330(1):e70021. doi: 10.1111/imr.70021.
8
From development to clinical success: the journey of established and next-generation BTK inhibitors.从研发到临床成功：成熟及新一代布鲁顿酪氨酸激酶（BTK）抑制剂的历程
Invest New Drugs. 2025 Apr;43(2):377-393. doi: 10.1007/s10637-025-01513-y. Epub 2025 Feb 27.
9
Decoding Immunobiology Through Genetic Errors of Immunity.通过免疫遗传错误解码免疫生物学
Annu Rev Immunol. 2025 Apr;43(1):285-311. doi: 10.1146/annurev-immunol-082323-124920. Epub 2025 Feb 14.
10
Sequelae of B-Cell Depleting Therapy: An Immunologist's Perspective.B细胞耗竭疗法的后遗症：免疫学家的观点
BioDrugs. 2025 Jan;39(1):103-130. doi: 10.1007/s40259-024-00696-9. Epub 2024 Dec 16.
Zotero 插件